Showing 901-910 of 10544 results for "".
What to Know About Sunscreens and More
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/what-to-know-about-sunscreens-and-more/19888/Henry Lim, MD summarizes a presentation from San Diego Dermatology Symposium, offering updates on sunscreen labeling and more.Scientifically Speaking: Botulinum Toxin Formulation and Testing
https://practicaldermatology.com/videos/scientifically-speaking/scientifically-speaking-botulinum-toxin-formulation-and-testing/19832/Ever wonder about the differences in formulation and manufacture of botulinum neurotoxins? Curious about the trials that support approval? In this edition of Scientifically Speaking, Joel L. Cohen, MD gets the answers to these questions and more from Conor Gallagher, PhD, Head of Medical Affairs, ReShould I Recommend Products that Claim to Contain Probiotics?
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/should-i-recommend-products-that-claim-to-contain-probiotics/19829/The language of the microbiome can be confusing. Dr. Friedman prefers to focus on symbiotics when making topical product recommendations.Improving Mastectomy Scars with the Vbeam Prima
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/improving-mastectomy-scars-with-the-vbeam-prima/19692/Many women with breast cancer will undergo a mastectomy, resulting in major scarring on the breasts. Jill Waibel, MD is passionate about helping these women get the treatment they deserve post-surgery and uses the Vbeam Prima, a pulsed dye laser device, to help improve the appearance of the scars. WUpdates from Principia, Sebacia, and Candela
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-updates-from-principia-sebacia-and-candela/19571/Phase 2 data for from the Believe-PV study for PRN1008 show that the investigational agent from Principia Biopharma reached the primary efficacy measure in pemphigus. Data confirm that Sebacia microparticles confer benefit in the management of acne vulgaris in real-world settings. Candela has rebranAntibiotics and the Mutant Selection Window
https://practicaldermatology.com/topics/atopic-dermatitis/antibiotics-and-the-mutant-protection-window/19537/When considering antibiotics for treating acne, Hilary Baldwin, MD says there's a new concept dermatologists should consider in preventing antibiotic resistance. She describes the mutant selection window and why a higher dose antibiotic may actually be safer and more effective.Guidelines for PsO, SRT; Promising Data from Sienna
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-guidelines-for-pso-srt-promising-data-from-sienna/19551/Two new guidelines from the American Academy of Dermatology and the National Psoriasis Foundation outline best practices for treating psoriasis, with a focus on comorbidities and biologic treatment. A new retrospective study shows a cure rate above 97 percent among older patients treated with superfNew eRelevance Services, Cosmetic Bootcamp Updates, Leo & AID Partnership
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-new-erelevance-services-cosmetic-bootcamp-updates-leo-aid-partnership/18291/eRelevance has launched a suite of 4 services intended to support aesthetic practices in optimizing their marketing strategies to capture, convert, and retain patients. CEO Bob Fabbio discusses. Aesthetic education takes center stage at Cosmetic Boot Camp in Aspen. The meeting is open only to boardDermatology Marketers Should Optimize Videos for Better Results
https://practicaldermatology.com/topics/practice-management/videocontent/18323/Creating video content is important for the promotion of your dermatology practice and it's time to start, if you haven't already done so. This Ekwa Marketing video explains how you can do this and achieve higher search rankings for your dermatology videos and integrate video marketing successfullyNPF Services, Eskata Update, AAD Meeting Data
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-npf-services-eskata-update-aad-meeting-data/18326/The National Psoriasis Foundation is expanding its services to patients, with a special focus on teens affected by the Skin Disease. Widely anticipated by both physicians and patients, Eskata will be available for in-office use this spring. Aclaris CEO, Dr. Neal Walker addresses the launch, as well